Genentech (TECENTRIQ)
(https://tecentriq.com) 📸 Data Snapshot: June 19, 2026Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
The analysis detects a review_count of 2 across all pages while the proof_links_count remains at 0, which triggers the trust_theatre_flag for displaying feedback without external verification. While the site references FDA approval, it fails to provide direct outbound proof paths to external clinical trial registries or peer-reviewed journal publications within the evaluated text. This reliance on the brand’s established authority without providing accessible verification links constitutes moderate trust theatre in a pharmaceutical context.
Proof points are highly concentrated in the Indications and Important Safety Information sections, citing specific gene mutations and cancer stages. The ratio of verifiable medical evidence to vague assertions is high due to stringent FDA reporting requirements for drug manufacturers. However, the site suffers from a total absence of external proof paths in the metadata, as proof_links_count is 0 across all evaluated URLs despite the heavy clinical claims.
Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.
🛡️ Trust Signals — reviews, proof links, trust-theatre check
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 0 |
| /hcc.html | 2 | 0 |
| /sclc.html | 2 | 0 |
| /melanoma.html | 2 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
/hcc.html
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
/sclc.html
[
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
},
{
"@context": "https://schema.org",
"@type": "VideoObject",
"name": "Dear Danny Video for ES-SCLC | TECENTRIQ® (atezolizumab)",
"description": " Find information about TECENTRIQ® (atezolizumab) for extensive-stage small cell lung cancer (ES-SCLC). See full safety at the end of the video for more information.",
"thumbnailUrl": "https://cf-images.us-east-1.prod.boltdns.net/v1/static/6125588073001/9120be34-cad8-4fbe-a754-40287f1046bd/20d4730f-2d40-4541-be2d-06400cf2964e/1280x720/match/image.jpg",
"uploadDate": "2023-12-18T20:41:44.023Z",
"duration": "PT6M14.485S"
}
]
/melanoma.html
{
"@context": "http://schema.org",
"@type": "Organization",
"name": "Genentech",
"url": "https://www.gene.com/",
"logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
"description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
"contactPoint": {
"@type": "ContactPoint",
"telephone": "+1-877-436-3683",
"contactType": "customer service"
},
"address": {
"@type": "PostalAddress",
"streetAddress": "1 DNA Way",
"addressLocality": "South San Francisco",
"addressRegion": "California",
"postalCode": "94080",
"addressCountry": "US"
}
}
This page presents a snapshot of public data from Genentech (TECENTRIQ), captured on June 19, 2026, to show how machine logic reads Trust & Proof signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Genentech (TECENTRIQ): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://tecentriq.com to view the most current version of its content and see directly what this company is about and what it offers.